全文获取类型
收费全文 | 2672篇 |
免费 | 191篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 168篇 |
妇产科学 | 18篇 |
基础医学 | 273篇 |
口腔科学 | 67篇 |
临床医学 | 291篇 |
内科学 | 502篇 |
皮肤病学 | 67篇 |
神经病学 | 512篇 |
特种医学 | 362篇 |
外科学 | 173篇 |
综合类 | 36篇 |
一般理论 | 1篇 |
预防医学 | 143篇 |
眼科学 | 21篇 |
药学 | 136篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 115篇 |
出版年
2021年 | 25篇 |
2020年 | 22篇 |
2019年 | 23篇 |
2018年 | 41篇 |
2017年 | 27篇 |
2016年 | 32篇 |
2015年 | 45篇 |
2014年 | 41篇 |
2013年 | 73篇 |
2012年 | 59篇 |
2011年 | 69篇 |
2010年 | 81篇 |
2009年 | 105篇 |
2008年 | 74篇 |
2007年 | 107篇 |
2006年 | 100篇 |
2005年 | 91篇 |
2004年 | 75篇 |
2003年 | 73篇 |
2002年 | 69篇 |
2001年 | 65篇 |
2000年 | 70篇 |
1999年 | 64篇 |
1998年 | 114篇 |
1997年 | 128篇 |
1996年 | 119篇 |
1995年 | 85篇 |
1994年 | 96篇 |
1993年 | 109篇 |
1992年 | 50篇 |
1991年 | 38篇 |
1990年 | 50篇 |
1989年 | 68篇 |
1988年 | 65篇 |
1987年 | 42篇 |
1986年 | 50篇 |
1985年 | 58篇 |
1984年 | 34篇 |
1983年 | 30篇 |
1982年 | 35篇 |
1981年 | 45篇 |
1980年 | 27篇 |
1979年 | 27篇 |
1978年 | 17篇 |
1977年 | 32篇 |
1976年 | 30篇 |
1975年 | 16篇 |
1974年 | 11篇 |
1972年 | 10篇 |
1968年 | 10篇 |
排序方式: 共有2891条查询结果,搜索用时 15 毫秒
1.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations 总被引:4,自引:0,他引:4
We analyzed 11 consecutive unrelated cases of polyneuropathy due to transthyretin amyloidosis. Direct sequencing of the promoter region, exons, and splice junctions revealed that each patient was heterozygous for a mutation: six patients had valine 30 substituted by methionine (V30----M; Portuguese-Japanese type), one had threonine 60 substituted by alanine (T60----A; Appalachian type), and two had serine 77 substituted by tyrosine (S77----Y; Illinois type). In addition, two patients had previously undescribed mutation: phenylalanine 33 substituted by leucine (F33----L) and phenylalanine 64 substituted by leucine (F64----L). From present information, the probands of these novel mutations do not exhibit any pathology that clearly distinguishes them from individuals with the other mutations. The mutations extend the range of mutations associated with amyloidotic polyneuropathy. In our 11 patients, the different mutations did not seem to correlate with distinct clinical phenotypes. We developed PASA assays (PCR amplification of specific alleles) for each of the five mutations. PASA can be used by any diagnostic laboratory that can perform PCR to rapidly detect any of the known mutations. The minority of samples with an undescribed mutation can be sent to a specialty laboratory for delineation of the mutation by direct genomic sequencing. The presently described combination of methods may have widespread utility in the diagnosis of genetic disease. 相似文献
4.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
5.
6.
The Great Safety Performance model uses leading indicators to drive injury prevention and provides a process to improve a company's safety outcomes by maximizing the conditions for safety within the workplace. The model asserts that leaders and workers need to jointly create conditions whereby everyone will know what to do, be able to do it, be equipped to do it, want to do it, and experience interactions that support safe performance in their job duties. These factors are referred to as the conditions for great performance. The Great Safety Performance model can serve as a vehicle to quantify, document, and demonstrate the efforts a company invests to create a safe workplace with safe work practices. By using the Great Safety Performance model, organizations can design and implement a variety of high leverage improvement initiatives specific to their business situations. 相似文献
7.
8.
Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi 总被引:11,自引:0,他引:11
K Museyi E Van Dyck T Vervoort D Taylor C Hoge P Piot 《The Journal of infectious diseases》1988,157(5):1039-1043
An experimental enzyme immunoassay (EIA) for detecting serum IgG antibody to Haemophilus ducreyi was developed using an ultrasonicated whole-cell antigen. The mean optical densities (OD) for sera from men with proven chancroid from Nairobi (47 patients) and Bangkok (72 patients) were significantly higher than those obtained from Nairobi men with genital ulcers not due to H. ducreyi, from Nairobi men with urethritis, from pregnant women in Nairobi, and from European men with sexually transmitted disease. When an OD of 0.500 was taken as the cutoff value, 89% and 55% of men with proven chancroid in Nairobi and Bangkok, respectively, were positive for H. ducreyi antibody, as compared with 2%-17% in the control groups. A rise in OD was observed in five of 18 patients with clinical chancroid. These results confirm the development of circulating antibodies in chancroid and suggest that this EIA may be useful for the diagnosis and epidemiological study of H. ducreyi infection. 相似文献
9.
10.